<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="CAD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>CA-3-D001647001</iati-identifier>
  <reporting-org ref="CA-3" type="10">
   <narrative xml:lang="FR">Affaires &#xE9;trang&#xE8;res, Commerce et D&#xE9;veloppement Canada (MAECD)</narrative>
   <narrative xml:lang="EN">Foreign Affairs, Trade and Development Canada (DFATD)</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Appui aux essais cliniques pour un vaccin contre le virus Ebola</narrative>
   <narrative xml:lang="EN">Support to Clinical Trials for the Ebola Vaccine</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Ce projet vise &#xE0; soutenir les activit&#xE9;s que m&#xE8;ne le Canada li&#xE9;es aux essais cliniques des phases 2 et 3 en Afrique. Ces derniers ont pour but d&#x2019;acc&#xE9;l&#xE9;rer la v&#xE9;rification de l&#x2019;innocuit&#xE9; et de l&#x2019;efficacit&#xE9; des vaccins exp&#xE9;rimentaux ainsi que leur utilisation chez les populations &#xE0; risque, comme les travailleurs de la sant&#xE9; de premi&#xE8;re ligne et les premiers r&#xE9;pondants en Afrique. Les donn&#xE9;es probantes issues de ces essais devraient d&#xE9;terminer l&apos;innocuit&#xE9;, la r&#xE9;ponse immunitaire protectrice, les essais d&apos;efficacit&#xE9; et l&apos;utilisation de vaccins candidats dans les populations &#xE0; risque comme les travailleurs de la sant&#xE9; de premi&#xE8;re ligne et les premiers intervenants. L&#x2019;approbation des vaccins exp&#xE9;rimentaux en vue d&#x2019;une utilisation future pour pr&#xE9;venir la transmission du virus Ebola sera accord&#xE9;e en fonction des r&#xE9;sultats des essais cliniques.  Parmi les activit&#xE9;s men&#xE9;es par les &#xE9;quipes de recherche : 1) la coordination des pr&#xE9;paratifs sur le terrain afin de faciliter les essais cliniques, y compris les approbations nationales, le renforcement des capacit&#xE9;s des organisations africaines participant aux essais cliniques, le recrutement du personnel sur le terrain et des participants aux essais cliniques; 2) la planification, la surveillance et la r&#xE9;alisation des essais cliniques; 3) l&#x2019;analyse des r&#xE9;sultats et l&#x2019;&#xE9;tablissement de rapports sur ceux ci.  Ce projet est coordonn&#xE9; par le Centre de recherches pour le d&#xE9;veloppement international, en partenariat avec les Instituts de recherche en sant&#xE9; du Canada, l&#x2019;Agence de la sant&#xE9; publique du Canada et Affaires &#xE9;trang&#xE8;res, Commerce et D&#xE9;veloppement Canada. Des chercheurs canadiens ainsi que des &#xE9;tablissements et des chercheurs africains &#xE9;tablissent actuellement des partenariats dans le cadre de la mise en &#x153;uvre de ce projet afin d&#x2019;aider &#xE0; renforcer la capacit&#xE9; des &#xE9;tablissements et des chercheurs africains &#xE0; effectuer des travaux de recherche biom&#xE9;dicale de haut niveau, comme des essais cliniques, et de faciliter la collaboration future. De plus, le projet vise &#xE0; am&#xE9;liorer le partage des connaissances sur le virus Ebola et sur des crises sanitaires semblables parmi les gouvernements et les organismes de recherche africains, afin de leur permettre d&#x2019;intervenir efficacement en cas d&#x2019;&#xE9;closions futures.</narrative>
   <narrative xml:lang="EN">The project aims to support Canadian activities towards phases 2 and 3 of clinical trials in Africa. These trials accelerate safety and efficacy testing and use of vaccine candidate(s) among at-risk populations such as front-line health-care workers and first-responders in Africa. Evidence from these trials should determine the safety, protective immune response, efficacy testing and use of vaccine candidate(s) in at-risk populations such as front-line health-care workers and first-responders. The results inform the approval of vaccine candidates for future use to prevent Ebola transmission.  Activities led by the research teams include: (1) coordinating in-field preparations to facilitate the clinical trial, including: national approvals, capacity building of Africa organizations involved in the clinical trial, recruitment of field personnel and clinical trials participants; (2) planning, oversight and execution of the clinical trial; and (3) analyzing and reporting of results.  This project is coordinated by International Development Research Centre (IDRC), in partnership with Canadian Institutes of Health Research (CIHR), Public Health Agency of Canada (PHAC) and Department of Foreign Affairs, Trade and Development Canada (DFATD). Partnerships are being built between Canadian researchers with African institutions and researchers in the implementation of this project to help build the capacity of African researchers and institutions to conduct high-level biomedical research like clinical trials and facilitate future collaboration. In addition, the project improves knowledge sharing on Ebola and similar health emergencies among African governments and research organizations to enable them to effectively respond to future outbreaks.</narrative>
  </description>
  <participating-org ref="CA" role="1" type="10">
   <narrative xml:lang="EN">Canada</narrative>
   <narrative xml:lang="FR">Canada</narrative>
  </participating-org>
  <participating-org ref="CA-3" role="3" type="10">
   <narrative xml:lang="FR">Affaires &#xE9;trang&#xE8;res, Commerce et D&#xE9;veloppement Canada</narrative>
   <narrative xml:lang="EN">Foreign Affairs, Trade and Development Canada</narrative>
  </participating-org>
  <participating-org crs-channel-code="11000" ref="CA-CRA_ACR-2107511586" role="4" type="10">
   <narrative xml:lang="FR">CRDI - Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="EN">IDRC - International Development Research Centre</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2015-02-17" type="2"></activity-date>
  <activity-date iso-date="2017-03-31" type="3"></activity-date>
  <activity-date iso-date="2017-03-31" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Affaires &#xE9;trang&#xE8;res, Commerce et D&#xE9;veloppement Canada (MAECD)</narrative>
    <narrative xml:lang="EN">Foreign Affairs, Trade and Development Canada (DFATD)</narrative>
   </organisation>
   <email>info@international.gc.ca</email>
   <website>www.international.gc.ca</website>
   <mailing-address>
    <narrative xml:lang="EN">125 Sussex Drive, Ottawa, Ontario, K1A 0G2</narrative>
    <narrative xml:lang="FR">125, promenade Sussex, Ottawa (Ontario), K1A 0G2</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="GN" percentage="80"></recipient-country>
  <recipient-country code="LR" percentage="10"></recipient-country>
  <recipient-country code="SL" percentage="10"></recipient-country>
  <location>
   <location-reach code="2"></location-reach>
   <location-id code="2275384" vocabulary="G1"></location-id>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>6.500000 -9.500000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
  </location>
  <location>
   <location-reach code="2"></location-reach>
   <location-id code="2403846" vocabulary="G1"></location-id>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>8.500000 -11.500000</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
  </location>
  <location>
   <location-reach code="2"></location-reach>
   <location-id code="2420477" vocabulary="G1"></location-id>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>10.833330 -10.666670</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="1"></location-class>
  </location>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <policy-marker code="10" significance="1" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="EN">Adolescent (Youth) Issues</narrative>
   <narrative xml:lang="FR">Questions touchant les adolescents (jeunes)</narrative>
  </policy-marker>
  <policy-marker code="9" significance="1" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="EN">Children&apos;s issues</narrative>
   <narrative xml:lang="FR">Questions touchant les enfants</narrative>
  </policy-marker>
  <policy-marker code="13" significance="0" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="EN">ICT as a tool for development</narrative>
   <narrative xml:lang="FR">Les TIC comme outils de d&#xE9;veloppement</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="EN">Indigenous issues</narrative>
   <narrative xml:lang="FR">Questions touchant les populations autochtones</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="99" vocabulary-uri="https://www.international.gc.ca/department-ministere/open_data-donnees_ouvertes/dev/data_field_definitions-definitions_champs_donnees.aspx?lang=eng#a2">
   <narrative xml:lang="FR">Questions urbaines</narrative>
   <narrative xml:lang="EN">Urban issues</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <budget status="2" type="1">
   <period-start iso-date="2014-04-01"></period-start>
   <period-end iso-date="2015-03-31"></period-end>
   <value currency="CAD" value-date="2015-02-17">3000000</value>
  </budget>
  <budget status="2" type="1">
   <period-start iso-date="2017-04-01"></period-start>
   <period-end iso-date="2018-03-31"></period-end>
   <value currency="CAD" value-date="2015-02-17">0</value>
  </budget>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2015-02-19"></transaction-date>
   <value currency="CAD" value-date="2015-02-19">3000000</value>
   <receiver-org ref="CA-CRA_ACR-2107511586"></receiver-org>
   <flow-type code="10"></flow-type>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2015-02-17"></transaction-date>
   <value currency="CAD" value-date="2015-02-17">3000000.01</value>
   <flow-type code="10"></flow-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <document-link format="TEXT/HTML" url="http://w05.international.gc.ca/projectbrowser-banqueprojets/project-projet/details/D001647001?Lang=eng">
   <title>
    <narrative xml:lang="EN">Description</narrative>
   </title>
   <category code="A02"></category>
   <category code="A08"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="http://w05.international.gc.ca/projectbrowser-banqueprojets/project-projet/details/D001647001?Lang=fra">
   <title>
    <narrative xml:lang="FR">Description</narrative>
   </title>
   <category code="A02"></category>
   <category code="A08"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://search.open.canada.ca/en/gc/?sort=score%20desc&amp;page=1&amp;search_text=D001647001">
   <title>
    <narrative xml:lang="FR">Proactive disclosure</narrative>
   </title>
   <category code="A06"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://rechercher.ouvert.canada.ca/fr/gc/?sort=score desc&amp;page=1&amp;search_text=D001647001">
   <title>
    <narrative xml:lang="FR">Divulgation proactive</narrative>
   </title>
   <category code="A06"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.idrc.ca">
   <title>
    <narrative xml:lang="EN">Activity website</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="http://www.idrc.ca/FR/Pages/default.aspx">
   <title>
    <narrative xml:lang="FR">Site web de l&apos;activit&#xE9;</narrative>
   </title>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <conditions attached="0"></conditions>
  <result type="2">
   <title>
    <narrative xml:lang="EN">Expected Results</narrative>
    <narrative xml:lang="FR">R&#xE9;sultats escompt&#xE9;s</narrative>
   </title>
   <indicator measure="5">
    <title>
     <narrative xml:lang="EN">Results expected</narrative>
     <narrative xml:lang="FR">R&#xE9;sultats escompt&#xE9;s</narrative>
    </title>
    <description>
     <narrative xml:lang="FR">Parmi les r&#xE9;sultats interm&#xE9;diaires escompt&#xE9;s du projet : 1) produire des donn&#xE9;es probantes sur l&#x2019;innocuit&#xE9;, la r&#xE9;ponse immunitaire protectrice et l&#x2019;efficacit&#xE9; du vaccin en vue d&#x2019;une administration aux populations &#xE0; risque; 2) d&#xE9;terminer la dose minimale efficace de vaccin n&#xE9;cessaire pour produire une r&#xE9;action immunitaire ad&#xE9;quate; 3) am&#xE9;liorer la capacit&#xE9; des chercheurs africains &#xE0; r&#xE9;aliser des essais cliniques.</narrative>
     <narrative xml:lang="EN">The expected intermediate outcomes for this project include: 1) generate evidence of safety, protective immune response, and efficacy of the vaccine for use in populations at risk of exposure; 2) determine minimum effective dose of vaccine required to achieve adequate immune response; and 3) enhance capacity of African researchers to conduct clinical trials.</narrative>
    </description>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
